|
|
Blood, 15 January 2005, Vol. 105, No. 2, pp. 855-861.
Prepublished online as a Blood First Edition Paper on July 15, 2004; DOI 10.1182/blood-2004-01-0177.
Previous Article | Table of Contents | Next Article 
TRANSFUSION MEDICINE
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
Timothy G. St. Pierre,
Paul R. Clark,
Wanida Chua-anusorn,
Adam J. Fleming,
Gary P. Jeffrey,
John K. Olynyk,
Pensri Pootrakul,
Erin Robins, and
Robert Lindeman
From the School of Physics and School of Medicine and Pharmacology, University of Western Australia, Perth, Australia; Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Australia; Thalassemia Research Center, Mahidol University, Bangkok, Thailand; SKG Radiology, St John of God Hospital, Perth, Australia; and Department of Haematology, Prince of Wales Hospital, Sydney, Australia.
Measurement of liver iron concentration (LIC) is necessary for a range of iron-loading disorders such as hereditary hemochromatosis, thalassemia, sickle cell disease, aplastic anemia, and myelodysplasia. Currently, chemical analysis of needle biopsy specimens is the most common accepted method of measurement. This study presents a readily available noninvasive method of measuring and imaging LICs in vivo using clinical 1.5-T magnetic resonance imaging units. Mean liver proton transverse relaxation rates (R2) were measured for 105 humans. A value for the LIC for each subject was obtained by chemical assay of a needle biopsy specimen. High degrees of sensitivity and specificity of R2 to biopsy LICs were found at the clinically significant LIC thresholds of 1.8, 3.2, 7.0, and 15.0 mg Fe/g dry tissue. A calibration curve relating liver R2 to LIC has been deduced from the data covering the range of LICs from 0.3 to 42.7 mg Fe/g dry tissue. Proton transverse relaxation rates in aqueous paramagnetic solutions were also measured on each magnetic resonance imaging unit to ensure instrument-independent results. Measurements of proton transverse relaxivity of aqueous MnCl2 phantoms on 13 different magnetic resonance imaging units using the method yielded a coefficient of variation of 2.1%.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Liver iron measurement by MRI
- John B. Porter
Blood 2005 105: 437-438.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
H. Chandarana, R. P. Lim, J. H. Jensen, C. H. Hajdu, M. Losada, J. S. Babb, S. Huffman, and B. Taouli
Hepatic Iron Deposition in Patients With Liver Disease: Preliminary Experience With Breath-Hold Multiecho T2*-Weighted Sequence
Am. J. Roentgenol.,
November 1, 2009;
193(5):
1261 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Chavhan, P. S. Babyn, B. Thomas, M. M. Shroff, and E. M. Haacke
Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special Applications
RadioGraphics,
September 1, 2009;
29(5):
1433 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pineda, P. Sharma, Q. Xu, X. Hu, M. Vos, and D. R. Martin
Measurement of Hepatic Lipid: High-Speed T2-Corrected Multiecho Acquisition at 1H MR Spectroscopy--A Rapid and Accurate Technique
Radiology,
August 1, 2009;
252(2):
568 - 576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hankins, M. B. McCarville, R. B. Loeffler, M. P. Smeltzer, M. Onciu, F. A. Hoffer, C.-S. Li, W. C. Wang, R. E. Ware, and C. M. Hillenbrand
R2* magnetic resonance imaging of the liver in patients with iron overload
Blood,
May 14, 2009;
113(20):
4853 - 4855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella and E. Poggiali
Towards explaining "unexplained hyperferritinemia"
Haematologica,
March 1, 2009;
94(3):
307 - 309.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Melis, M. Cau, R. Congiu, G. Sole, S. Barella, A. Cao, M. Westerman, M. Cazzola, and R. Galanello
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron
Haematologica,
October 1, 2008;
93(10):
1473 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Taher, F. El Rassi, H. Isma'eel, S. Koussa, A. Inati, and M. D. Cappellini
Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia
Haematologica,
October 1, 2008;
93(10):
1584 - 1586.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Origa, S. Barella, G. M. Argiolas, P. Bina, A. Agus, and R. Galanello
No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia
Haematologica,
July 1, 2008;
93(7):
1095 - 1096.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Angelucci, G. Barosi, C. Camaschella, M. D. Cappellini, M. Cazzola, R. Galanello, M. Marchetti, A. Piga, and S. Tura
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
Haematologica,
May 1, 2008;
93(5):
741 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Nathan
Oral iron chelation: new drug, old rules
Blood,
January 15, 2008;
111(2):
483 - 484.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rose, O. Ernst, B. Hecquet, P. Maboudou, P. Renom, M. P. Noel, I. Yakoub-Agha, F. Bauters, and J. P. Jouet
Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long-term survivors after allogeneic hematopoietic stem cell transplantation
Haematologica,
June 1, 2007;
92(6):
850 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aessopos, C. Fragodimitri, F. Karabatsos, A. Hatziliami, J. Yousef, A. Giakoumis, A. Dokou, E. D. Gotsis, V. Berdoukas, and M. Karagiorga
Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia
Haematologica,
January 1, 2007;
92(1):
131 - 132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem.,
June 1, 2006;
52(6):
950 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Neufeld
Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
Blood,
May 1, 2006;
107(9):
3436 - 3441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Blood,
December 1, 2005;
106(12):
3710 - 3717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. St. Pierre, G. P. Jeffrey, E. Rossi, A. J. Fleming, W. Chua-anusorn, P. R. Clark, and J. K. Olynyk
A New Model for Predicting Venesection Therapy Requirements in Hereditary Hemochromatosis Using Non-Invasive Liver Iron Concentration Measurement.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
3596 - 3596.
[Abstract]
|
 |
|

|
 |

|
 |
 
J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
Blood,
August 15, 2005;
106(4):
1460 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, H. Pollack, and R. Moats
Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy
Circulation,
July 26, 2005;
112(4):
535 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|